Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
RentRedi Recognized as a 2025 Inc. Power Partner Award Winner for Third Consecutive Year
-
NAPC Defense Launches Grant Initiative to Equip School Resource Officers Nationwide with CornerShot Tactical Systems
-
The Metals Company Announces Third Quarter 2025 Corporate Update Conference Call for Thursday, November 13, 2025
-
IMUNON to Hold Third Quarter 2025 Financial Results and Business Update Conference Call on Thursday, November 13, 2025
-
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025
-
Raise Craze, a partnership between the MUHC Foundation, The Beat 92.5, and Pink in the City, raised $162,160 for breast cancer care at the MUHC
-
Skyharbour’s Partner Mustang Energy Corp. Announces Results of TDEM Survey Over the 914W Property
-
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results
-
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Journal of the American Academy of Special Education Professionals (JAASEP), a publication of the National Association of Special Education Teachers (NASET), announces new editorial leadership and the
-
Greenridge Exploration Highlights Successful Results of Airborne Electromagnetic and Radiometric Survey for the Flying Vee Project
-
8MBets Online Casino Nepal Celebrates Successful 1st Year and Aims to Become the Best Online Casino in Nepal
-
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences
-
VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update
-
Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors
-
QieDex Unveils Decentralized Trading and Token Creation Platform on the Lightning-Fast QIE Network
-
Noom Unveils New Diabetes Lifestyle Program and Predictive Glucose Forecasting to Tackle America’s Diabetes Crisis
-
Cytrellis Secures FDA Clearance for Full Body Resurfacing Using Ellacor® Micro-Coring® Technology
-
Timeless Builds: Specialist Pool and Backyard Remodeling Company Announces Immersive New Website
-
Celldex Presents Results from Barzolvolimab Phase 2 Study in Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Demonstrating Sustained Efficacy and Favorable Safety Profile over 20 Week Placeb
-
Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025
-
Imbria Pharmaceuticals Announces First Patient Randomized in FORTITUDE-HCM Phase 2b Clinical Trial Evaluating Ninerafaxstat for Non-Obstructive Hypertrophic Cardiomyopathy
-
For the Second Consecutive Year, Provident Bank Announces $50,000 in Grants to 6 Non-Profit Organizations
-
Aemetis Reports Third Quarter 2025 Financial Results
-
Feed a Family of 10 for Under $40 this Thanksgiving: Stop & Shop Introduces One of the Season’s Best Dinner Deals
-
*MEDIA ALERT* Verizon and David Beckham Launch First-Ever "Golden Ticket" Sweepstakes for FIFA World Cup 26™
-
Sironax Announces Three Abstracts Selected for Presentation at Neuroscience 2025
-
Evotrex Exits Stealth with $16 Million Pre-A to Debut the World’s First Power-Generating RV Trailer at CES 2026
-
Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015
-
Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update
-
Enphase Energy IQ8 Microinverters Power Solar Projects at Gas Stations Worldwide
-
Zscaler to Host First Quarter Fiscal Year 2026 Earnings Conference Call
-
STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansio
-
HPQ CEO Applauds and Comments on Canada’s New Federal Budget and Its Positive Impact on HPQ’s Technology Portfolio
-
Celldex Presents Additional Positive Data Demonstrating Barzolvolimab’s Ability to Drive Rapid, Profound and Durable Complete Urticaria Control in Phase 2 Chronic Spontaneous Urticaria (CSU) Study
-
LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates
-
Melco Announces Unaudited Third Quarter 2025 Earnings
-
Skyworks Introduces New Programmable Bulk Acoustic Wave Clocks for 5G, 6G, and Data Center Applications
-
Form 8.3 - IDOX plc - Octopus Investments
-
MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
-
BioCryst Presents New Data at ACAAI Highlighting Burden of HAE on Pediatric Patients and Caregivers and Sustained Reduction of Attacks in Children Treated with One Year of ORLADEYO® (berotralstat)
-
Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025
-
Asure Software Sets November and December 2025 Investor Conference Schedule
-
Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer’s Program
-
*MEDIA ALERT* Verizon and David Beckham Launch First-Ever "Golden Ticket" Sweepstakes for FIFA World Cup 26™
-
SunCar’s Investment in its AI Technology Development Center Driving Strong Premium Sales for its EV Partners
-
GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs: COYY, TSYY, NVYY, XBTY, AMYY, TQQY, AZYY, YSPY, MTYY, PLYY, HOYY, SMYY, BBYY, FBYY, IOYY and MAAY
-
SharpLink to Host Third Quarter 2025 Financial Results Conference Call and Webcast on November 13, 2025 at 8:30 A.M. E.T.
-
Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis
-
LiveOne (Nasdaq: LVO) to Announce Its Second Quarter Fiscal Year 2026 Financial Results and Host Investor Webcast on November 12, 2025, at 10:00 am Eastern Time (7:00 am Pacific Time)
